Winmark Corp grants director stock options at $444.54 per share
Winmark Corp reported an equity award to one of its directors.
Rhea-AI Filing Summary
Winmark Corp reported an equity award to one of its directors. On 12/15/2025, the director received a non-employee stock option to buy 256 shares of common stock at an exercise price of $444.54 per share. The option is scheduled to vest 25% per year for four years and will be exercisable beginning 12/15/2026, with an expiration date of 12/15/2035. The filing also shows the director beneficially owns a separate non-employee stock option covering 3,000 shares at a $393.64 exercise price, exercisable from 08/07/2026 until 08/07/2035.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Employee Stock Option (right to buy) | 256 | $444.54 | $114K |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
Footnotes (1)
- F1. 25% per year for four years.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Winmark Corp (WINA) report in this filing?
The filing reports that a Winmark Corp director received a non-employee stock option on 12/15/2025 covering 256 shares of common stock.
What is the exercise price and term of the new Winmark Corp director options?
The new option has an exercise price of $444.54 per share, becomes exercisable on 12/15/2026, and expires on 12/15/2035.
What is the vesting schedule of the new Winmark Corp non-employee stock option?
According to the footnote, the option vests 25% per year for four years.
What other stock options does the Winmark Corp (WINA) director hold according to this report?
The report also lists a separate non-employee stock option for 3,000 shares of common stock with a $393.64 exercise price, exercisable from 08/07/2026 until 08/07/2035.
AI-generated analysis. How Rhea-AI works. Not financial advice.